Author:
Delea Thomas E.,Tappenden Paul,Sofrygin Oleg,Browning Dominy,Amonkar Mayur M.,Karnon Jon,Walker Mel D.,Cameron David
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference55 articles.
1. Hung, M.-C., Lau, Y.-K.: Basic science of HER-2/neu: a review. Semin. Oncol. 26(Suppl 12), 51–59 (1999)
2. Woodburn, J.R.: The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol. Ther. 82(2–3), 241–250 (1999)
3. Nicholson, R.I., Gee, J.M.W., Harper, M.E.: EGFR & cancer prognosis. Eur. J. Cancer 37(Suppl 4), 9–15 (2001)
4. Mackey, J., McLeod, D., Ragaz, J., Gelmon, K., Verma, S., Pritchard, K., Laing, K., Provencher, L., Charbonneau, L.F.: Adjuvant targeted therapy in early breast cancer. Cancer 115(6), 1154–1168 (2009)
5. Jackisch, C.: HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy. Oncologist 11(Suppl 1), 34–41 (2006)
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献